What is Sleep?
The Sleep Disorders Center of Connecticut operates as a premier clinical entity dedicated to the comprehensive evaluation and treatment of sleep-related pathologies. Accredited by the American Academy of Sleep Medicine, the organization distinguishes itself through a multidisciplinary approach, integrating board-certified sleep specialists and psychologists to address complex conditions such as insomnia, sleep apnea, and restless legs syndrome. The facility is uniquely positioned within the healthcare landscape by offering both in-lab diagnostics and home sleep testing, ensuring high-quality, patient-centric care for adults and children aged seven and older. By utilizing cutting-edge technology and cognitive behavioral therapy, the center maintains a competitive edge in the clinical sleep medicine market, prioritizing both diagnostic accuracy and patient confidentiality.
How much funding has Sleep raised?
Sleep has raised a total of $526K across 2 funding rounds:
Debt
$150K
Debt
$376K
Debt (2020): $150K with participation from PPP
Debt (2021): $376K led by PPP
Key Investors in Sleep
PPP
Public-Private Partnership
What's next for Sleep?
With the recent strategic investment, the Sleep Disorders Center of Connecticut is well-positioned to accelerate its clinical expansion and technological integration. Future initiatives are expected to focus on the optimization of CPAP acclimatization programs and the broader adoption of digital health tools to streamline patient assessments. As the organization navigates the evolving healthcare regulatory environment, the focus will likely remain on scaling its specialized service offerings while maintaining the rigorous standards required for AASM accreditation. This capital deployment strategy suggests a long-term commitment to enhancing the standard of care for sleep disorders, potentially paving the way for increased market penetration and the development of new, specialized treatment pathways for a wider patient demographic.
See full Sleep company page